We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Paul Wang

Paul Wang MD

Dr. Wang is the Director ofthe StanfordCardiac ArrhythmiaService.  Dr. Wang received his undergraduate degree at Harvard University and his medical degree at Columbia University in New York City. He received his medical residency at Columbia-Presbyterian Medical Center in New York City and completed his cardiovascular training at Brigham and Women’s Hospital, a major teaching institution of Harvard Medical School. He was Associate Director of Cardiac Electrophysiology Laboratory at Tufts-New England Medical Center in Boston for 14years prior to coming to direct the Stanford Cardiac Arrhythmia Service. He has co-authored textbooks on implantable defibrillators, sudden cardiac death, cardiac resynchronization/ biventricular pacing therapy, and innovations in arrhythmia therapy, and has invented a number of new arrhythmia technologies, including catheter. Dr. Wang participates on numerous national boards and panels in cardiac electrophysiology. He is a member of the American Heart Association Council on Clinical Cardiology ECG and Arrhythmias Committee and the American College of Cardiology Electrophysiology Committee. He served as a member of the Cardiac Electrophysiology Board Certification Exam Writing Committee of the American Board of Internal Medicine. He serves on the Continuing Medical Education Subcommittee of the Education Committee of the Heart Rhythm Society.  Dr. Wang is Co-Director of the Bioengineering Scholarly Concentration of the Stanford School of Medicine.

Dr. Wang's research studies centers on the development of innovative approaches to the treatment of arrhythmias, including catheter ablation, implantable devices, and diagnostic techniques. Dr. Wang is co-inventor of a cryoablation method and device that has been the basis of a cryoablation catheter which has been FDA approved for about six years (Cryocath, Inc. recently acquired by Medtronic, Inc.).  Dr. Wang’s contributions have lead to development of a real-time correlation wave form analysis and T wave subtraction technique that has been incorporated into EP laboratory systems.  Dr. Wang is working on several novel approaches to treatment of arrhythmias using catheter and surgical ablation.  

Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, syncope, and hypertrophic cardiomyopathy.

Recent Contributions to PracticeUpdate:

  1. Generator Exchange and Increased Rate of ICD Lead Alerts